Closed
GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure
Request tender documents
Save your time. You just request and we will send you the available documents.
Request for bid service
Save your time. You just request and we will arrange tender related all available documents to bid writers for the best possible quote.
Descriptions
The University of Liverpool, through its LONGEVITY project funded by Unitaid, is implementing product development and commercialization of Long-Acting Injectable (LAI) formulations for malaria and tuberculosis prevention, and a hepatitis C virus cure for Low- and Middle-Income Countries (LMIC's). The University of Liverpool was awarded 32 million US dollars in early 2020 from Unitaid (https://unitaid.org/) as part of the 40 million US dollar project to fund these activities to commercialisation.https://unitaid.org/news-blog/unitaid-invests-in-long-acting-medicines-to-simplify-treatment-and-prevention-for-hiv-tb-malaria-and-hcv/#en https://www.liverpool.ac.uk/chemistry/news/articles/24m-boost-for-revolutionary-long-acting-medicine-research/ The TB and HCV products are reaching the end of proof-of-concept studies and the University of Liverpool is seeking quotations for provision of GLP toxicology services to support product clinical stage progress. Full outline of study requirements available from the University of Liverpool's tendering website (details included in other information section below)
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
73111000 - Research laboratory services
Keywords
chemical testing
sample analysis
lab testing
scientific trials
controlled experiments
measurement validation
laboratory reporting
instrumentation services
analytical procedures
biological assays
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Buyer Information
Name :
